Isaac Health GUIDE model has launched – click here to book

 

The best care for every brain™

Magazine

Understanding FTD: What You Need to Know About the Most Common Dementia Under 60, Its Causes, Symptoms, and Treatment Options, in Light of Bruce Willis’ Diagnosis

As a behavioral neurologist and researcher at NYU Langone Health and the Chief Medical Officer of Isaac Health, I was recently interviewed by several media outlets for my expertise and insights on frontotemporal degeneration (FTD), also known as frontotemporal dementia. The recent news about actor Bruce Willis being diagnosed with FTD has brought this condition …

Understanding FTD: What You Need to Know About the Most Common Dementia Under 60, Its Causes, Symptoms, and Treatment Options, in Light of Bruce Willis’ Diagnosis Read More »

Join Isaac Health and the Alzheimer’s Association for a Presentation on Early Detection of Dementia

Are you or someone you know experiencing early changes in memory or thinking? Do you want to learn how to keep your brain healthy or reduce your risk of developing dementia? If so, join Isaac Health and the Alzheimer’s Association for a presentation on early detection of dementia by Dr. Joel Salinas, Founder & CMO …

Join Isaac Health and the Alzheimer’s Association for a Presentation on Early Detection of Dementia Read More »

The Impact of Daily Microstress on Your Brain: New Insights from Karen Dillon and Rob Cross

Are you aware of the impact that microstress is having on your daily life and overall health? Most of us know the effects of stress in general, but microstress can be more insidious, creeping into our lives unnoticed, and building up over time. In their upcoming book, “The Microstress Effect: How Little Things Pile Up …

The Impact of Daily Microstress on Your Brain: New Insights from Karen Dillon and Rob Cross Read More »

What Does Dementia Care Cost? Alzheimer’s, resources, dementia, car

What Does Dementia Care Cost?

Compared to caregiving for a person without dementia, caregivers of a loved one with dementia are two times more likely to experience severe financial difficulties – 70% of total lifetime costs of caring for someone with dementia is borne by families.

FDA Approves New Alzheimer’s Drug, Leqembi

January 9th, 2023 — The US Food and Drug Administration (FDA) has recently approved amyloid-targeting drug Leqembi (lecanemab) for the treatment of early stage Alzheimer’s disease. This is a historic development for those affected by this debilitating disease and their loved ones. Lecanemab demonstrated promising results in clinical trials, with patients experiencing a 27 percent …

FDA Approves New Alzheimer’s Drug, Leqembi Read More »

Request patient flyers